Natasha Strydom

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Pulmonary Tuberculosis

Top Venues

Nature communications

CPT: pharmacometrics & systems pharmacology

Antimicrobial agents and chemotherapy

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Natasha Strydom, Jacqueline P Ernest, Marjorie Imperial, Belen P Solans, Qianwen Wang, Rokeya Tasneen, Sandeep Tyagi, Heena Soni, Andrew Garcia, Kristina Bigelow, Martin Gengenbacher, Matthew Zimmerman, Min Xie, Jansy P Sarathy, Tian J Yang, Veronique Anne Dartois, Eric L Nuermberger, Radojka M Savic
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen. Nature communications 15 (1) (2024)
Natasha Strydom, Jacqueline P Ernest, Marjorie Imperial, Belen P Solans, Qianwen Wang, Rokeya Tasneen, Sandeep Tyagi, Heena Soni, Andrew Garcia, Kristina Bigelow, Martin Gengenbacher, Matthew Zimmerman, Min Xie, Jansy P Sarathy, Tian J Yang, Veronique Anne Dartois, Eric L Nuermberger, Radojka M Savic
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen. Nature communications 15 (1) (2024)
Natasha Strydom, Jacqueline P Ernest, Marjorie Imperial, Belen P Solans, Qianwen Wang, Rokeya Tasneen, Sandeep Tyagi, Heena Soni, Andrew Garcia, Kristina Bigelow, Martin Gengenbacher, Matthew Zimmerman, Min Xie, Jansy P Sarathy, Tian J Yang, Veronique Anne Dartois, Eric L Nuermberger, Radojka M Savic
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen. Nature communications 15 (1) (2024)
William S Fox, Natasha Strydom, Marjorie Z Imperial, Leah G Jarsberg, Radojka M Savic
Examining nonadherence in the treatment of tuberculosis: The patterns that lead to failure. British journal of clinical pharmacology (2022)
Karen Rowland Yeo, Stefanie Hennig, Sriram Krishnaswami, Natasha Strydom, Vivaswath S Ayyar, Jonathan L French, Vikram Sinha, Eric Sobie, Ping Zhao, Lena E Friberg, France Mentré
CPT: Pharmacometrics & Systems Pharmacology - Inception, Maturation, and Future Vision. CPT: pharmacometrics & systems pharmacology 10 (7) (2022)
Maria Garcia-Cremades, Craig W Hendrix, Priya Jayachandran, Natasha Strydom, Leah Jarlsberg, Robert Grant, Connie L Celum, Michael Martin, Jared M Baeten, Jeanne Marrazzo, Peter Anderson, Kachit Choopanya, Suphak Vanichseni, David V Glidden, Radojka M Savic
Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis. Pharmaceutics 14 (9) (2022)
Hwi-Yeol Yun, Min Jung Chang, Heeyoon Jung, Vincent Chang, Qianwen Wang, Natasha Strydom, Young-Ran Yoon, Radojka M Savic
Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients. Antimicrobial agents and chemotherapy 66 (9) (2022)
John Fors, Natasha Strydom, William S Fox, Ron J Keizer, Radojka M Savic
Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis. PLoS computational biology 16 (8) (2020)
Natasha Strydom, Sneha V Gupta, William S Fox, Laura E Via, Hyeeun Bang, Myungsun Lee, Seokyong Eum, Tae Sun Shim, Clifton Earl Barry, Matthew Zimmerman, Veronique Anne Dartois, Radojka M Savic
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization. PLoS medicine 16 (4) (2019)